News

Hester Biosciences announced that the Board of Directors of the Company at its meeting held on 15 May 2026, inter alia, have recommended the final dividend of Rs 11 per equity Share (i.e. 110%) , subject to the approval of the shareholders.

Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025. Sales rose 22.19% to Rs 100.11 crore in the quarter ended March 2026 as against Rs 81.93 crore during the previous quarter ended March 2025.For the full year,net profit rose 102.40% to Rs 55.64 crore in the year ended March 2026 as against Rs 27.49 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 332.60 crore in the year ended March 2026 as against Rs 311.10 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales100.1181.93 22 332.60311.10 7 OPM %34.2923.41 -26.0619.63 - PBDT28.067.92 254 91.7856.37 63 PBT22.153.75 491 72.9039.57 84 NP15.981.29 1139 55.6427.49 102 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 15 May 2026.

The board of Hester Biosciences at its meeting held on 11 March 2026 has approved the divestment of 43.81% equity stake out of total 54.81% in its subsidiary, Texas Lifesciences (TLPL), by way of transfer/sale of shares to the existing promoter shareholders of the TLPL for a consideration of Rs 9.2 crore. TLPL is not material subsidiary of the Company. TLPL will ceased to be the subsidiary of the Company upon completion share transfer transaction as above. Hester will continue to do business with TLPL and maintain an 11% equity stake/investment in the company. Powered by Capital Market - Live News

Net profit of Hester Biosciences declined 24.79% to Rs 8.77 crore in the quarter ended December 2025 as against Rs 11.66 crore during the previous quarter ended December 2024. Sales rose 22.46% to Rs 77.42 crore in the quarter ended December 2025 as against Rs 63.22 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales77.4263.22 22 OPM %22.998.02 - PBDT17.9617.66 2 PBT13.5213.37 1 NP8.7711.66 -25 Powered by Capital Market - Live News